Related Experiment Video
Updated: May 13, 2026
05:26
Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Advances in chitosan-based drug delivery vehicles
1College of Life Science and Bioengineering, Beijing University of Technology, No.100, Pingleyuan, Chaoyang, Beijing, 100124, China. huliming@bjut.edu.cn
Nanoscale
|March 22, 2013
Summary
Chitosan, a unique polysaccharide, offers excellent properties for drug delivery systems. This review explores its applications in polymeric drug conjugates and nanocarriers for enhanced therapeutic delivery.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery
Background:
- Chitosan is a versatile polysaccharide with unique properties for drug delivery.
- Its primary amino groups allow chemical modification, and it offers mucoadhesion for enhanced transport.
- Chitosan-based systems are increasingly studied for advanced therapeutic applications.
Purpose of the Study:
- To provide a comprehensive overview of chitosan-based drug delivery systems.
- To focus on polymeric drug conjugates and nanocarriers.
- To discuss their preparation methods and applications.
Main Methods:
- Literature review of chitosan-based drug delivery systems.
- Focus on polymeric drug conjugates and nanocarriers.
- Analysis of preparation techniques and therapeutic applications.
Main Results:
- Chitosan's unique characteristics make it ideal for drug delivery platforms.
- Polymeric chitosan-drug conjugates show promise in targeted therapies.
- Chitosan-based nanocarriers offer efficient encapsulation and controlled release.
Conclusions:
- Chitosan is a highly attractive biomaterial for developing innovative drug delivery vehicles.
- Polymeric conjugates and nanocarriers represent key areas of advancement.
- Further research into chitosan-based systems will enhance therapeutic efficacy and patient outcomes.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.